.AstraZeneca has actually discussed an early look at the functionality of its own in-house antibody-...
.After introducing a stage 3 launch based on positive midstage end results, iTeos and GSK are eventu...
.The FDA needs to be actually extra available and joint to let loose a surge in commendations of rar...
.It is actually an uncommonly active Friday for biotech IPOs, along with Zenas BioPharma, MBX as wel...
.Atea Pharmaceuticals' antiviral has actually neglected an additional COVID-19 trial, yet the biotec...
.Neurocrine Biosciences' mental illness plan pivot has neglected. The biotech was actually not able ...
.Sanofi has actually brought in a late entry to the radioligand gathering, paying out one hundred mi...
.After F2G's very first attempt to receive a brand-new course of antifungal to market was thwarted b...
.Moderna has promised to reduce R&D costs by $1.1 billion through 2027. The selection to shrink t...
.Just 4 months after Sanofi wager $80 thousand in ahead of time cash on Pivot Therapeutics' losmapim...